2010
DOI: 10.1186/1471-2415-10-1
|View full text |Cite
|
Sign up to set email alerts
|

Scoring and psychometric properties of the Eye-Drop Satisfaction Questionnaire (EDSQ), an instrument to assess satisfaction and compliance with glaucoma treatment

Abstract: BackgroundThe objective of this study was to ascertain the scoring and assess the psychometric properties of the Eye-Drop Satisfaction Questionnaire (EDSQ), a 43-item Patient-Reported Outcome instrument developed to assess patients' satisfaction and compliance with glaucoma treatment.MethodsThe EDSQ was administered during an observational, retrospective study to 184 French patients treated for glaucoma. The hypothesized structure, including six dimensions (patient-clinician relationship; patient experience; p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
34
0
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 38 publications
(36 citation statements)
references
References 26 publications
1
34
0
1
Order By: Relevance
“…The level of C83 is much higher than that of C99, which is expected since non-amyloidogenic cleavage by α-secretase is the predominant pathway for APP processing (Postina, 2008). We tested the effect of FAC on Aβ levels using a validated colorimetric ELISA (Dasari et al, 2010; Jayaraman et al, 2012; Thakker et al, 2009), which showed an increase in Aβ42, with no detectable change in Aβ40 (Fig. 3D).…”
Section: Resultsmentioning
confidence: 99%
“…The level of C83 is much higher than that of C99, which is expected since non-amyloidogenic cleavage by α-secretase is the predominant pathway for APP processing (Postina, 2008). We tested the effect of FAC on Aβ levels using a validated colorimetric ELISA (Dasari et al, 2010; Jayaraman et al, 2012; Thakker et al, 2009), which showed an increase in Aβ42, with no detectable change in Aβ40 (Fig. 3D).…”
Section: Resultsmentioning
confidence: 99%
“…[36], [38,39,40]] and for specific treatments [e.g. [41], [42]]. There are also some questionnaires assessing attitudes and beliefs toward CAM treatments [e.g.…”
Section: Resultsmentioning
confidence: 99%
“…In anderen Bereichen wurden spezielle krankheits-und therapiebezogene Bögen entwickelt und validiert, z. B. Eye-Drop Satisfaction Questionnaire, Osteoporosis Patient Treatment Satisfaction Questionnaire [7,20]. Für die internistisch-medikamentöse Therapie existieren ebenfalls validierte Scores [2].…”
Section: Zusammenfassung ▼unclassified